These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 12256570)

  • 21. [Estrogen and progesterone receptors in uterine cervix].
    Brentani MM; Lopes MT; Pereyra EG; Pacheco MM; Oshima CT; Widman A; De Almeida PC
    J Bras Ginecol; 1985; 95(9):411-5. PubMed ID: 12267713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cervical mucus. 1. Physicochemical properties].
    Garcea N; Moneta E; Iacobelli S; Bompiani A
    Ann Ostet Ginecol; 1970; 92():637-78. PubMed ID: 12256724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ovulation method of family planning.
    France JT
    IPPF Med Bull; 1973 Jun; 7(3):2-3. PubMed ID: 12306723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic changes in cervical mucus, and its practical importance.
    Guttmacher AF; Shettles LB
    Hum Fertil; 1940 Feb; 5(1):4-9. PubMed ID: 12305580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytological study in cases with intrauterine contraceptive device (Lippes' Loop).
    Aikat M; Pande M
    J Obstet Gynaecol India; 1968 Apr; 18(2):270-3. PubMed ID: 12331818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The sympto-thermal methods].
    Parenteau-carreau S
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1189-203. PubMed ID: 12312702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
    Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
    Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum sialic acids in the normal menstrual cycle: a possible test for the prediction of ovulation.
    Naguib YA; Darwish NA; Nabil ; Shaarawy M; Nagui AR; Thabet S
    J Egypt Soc Obstet Gynecol; 1978 Jan; 4(1):37-48. PubMed ID: 12309831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physical properties and PGE2 and PGF2 alpha content of cervical mucus in women wearing IUD compared to those not wearing IUD].
    Yao J; Zhou SW
    Shengzhi Yu Biyun; 1984 May; 4(2):51-3. PubMed ID: 12313204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Copper in the menstrual and physiological cycle cervical mucus of copper IUD users (author's transl)].
    Ros A; Bouche M; Adami L; Mancaniello L
    Contracept Fertil Sex (Paris); 1980 Jan; 8(1):11-6. PubMed ID: 12336140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fertility and characteristics of ovulation after discontinuing oral contraception].
    Gaspard U; Lambotte R
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mode of action of oral contraceptives.
    Fam Plann Inf Serv; 1978 Feb; 1(1):11. PubMed ID: 12308926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose progestagens as contraceptive agents.
    Elstein M
    IPPF Med Bull; 1970; 4(1):2-4. PubMed ID: 12255089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J; Schaaps JP; Lambotte R
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nor-ethisterone enanthate (SH 393) on the structure of the endometrium and on the cervical mucus.
    Achari K
    J Obstet Gynaecol India; 1969; 19(6):731-6. PubMed ID: 12255497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual disorders after sterilization with special reference to ovarian activity.
    Kishore N; Khambatta R; Mullick S
    J Obstet Gynaecol India; 1972 Apr; 22():180-4. PubMed ID: 12256847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pros and cons of triphasic oral contraception].
    Berdah J
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.